G90S (p.Gly90Ser) variant of CASQ2 (Calsequestrin-2)
G90S (p.Gly90Ser) in CASQ2 (Calsequestrin-2) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The record also includes structural context.
G90S (p.Gly90Ser) variant details
- p.Gly90Ser
- NCI-TCGA Cosmic COSV5476
- Variant assessed as somatic; moderate impact.
- Missense
- UniProt: Variant assessed as somatic; moderate impact.
- Structural context available